BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Oncol. Jul 24, 2026; 17(7): 121262
Published online Jul 24, 2026. doi: 10.5306/wjco.121262
Figure 3
Figure 3 Biological analysis of risk variants. A and B: Neurofibromin 1 Leu 190 (A) and secreted protein acidic and rich in cysteine (SPARC) Arg 255 (B) across species; C and D: Schematic diagrams of the 3D SPARC protein structure prior to and after C > D mutation, which altered the amino acid at position 255 from an arginine to a histidine.


Write to the Help Desk